Company / Net Income
LENZ Therapeutics, Inc. Net Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$82.1M
FY2025
5-year range
-$101.1M / -$49.8M
FY2021-FY2025
Trend
-65.0%
vs FY2024
Sector context
#102 of 216
Health Care
What the data says
At -$82M, LENZ Therapeutics, Inc.'s net income ranks #102 of 216 in the Health Care sector. Declined from -$70M to -$82M over the past 2 years.
Based on SEC 10-K filings.
-$82M in FY2025.
Declined from -$70M to -$82M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#102 of 216 in Health CareTop 47% of 216This company -$82.1M Sector average $454.3M
▼
-118.1% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 65.0% year-over-year.
- Ranks #102 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2024.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.71 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$82.1M | -65.0% |
| FY2024 | -$49.8M | +28.9% |
| FY2023 | -$70.0M | +30.8% |
| FY2022 | -$101.1M | -42.8% |
| FY2021 | -$70.8M | -3.5% |
| FY2020 | -$68.4M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026